Chronic Kidney Disease
Part of NephTimes
Researchers examined the roles of hyperuricemia and anemia in all-cause mortality with chronic kidney disease (CKD). The ERA reviewed phase 3 trials to clarify the mechanism behind HIF-PHi and their role in managing CKD-related anemia. Research has begun to question recommendations to restrict potassium with CKD to manage hyperkalemia. A super-learner strategy gave accurate risk predictions of kidney failure and death for people with moderate to severe CKD. Researchers uncovered clinical and economic of the Kidney BEAM physical activity digital health intervention for CKD. Use of antidepressants among patients with CKD is widespread but few data are available on their safety in this population. Few data are available on the role of statins for preventing ASCVD in patients with moderate chronic kidney disease. A simulation model predicts a dramatic increase in the impact of chronic kidney disease in the next 10 years. Kavita Mistry and Marcelle Tuttle will be the American Kidney Fund 2024 Clinical Scientist in Nephrology Fellows. The RPA and ASN called for a halt in reductions to Medicare payments to nephrology practices participating in the KCC model. A group of experts including the ASN, ERA, and ISN joined together to push for global action on chronic kidney disease (CKD). Yanlin Wang of UConn Health has won the VA's Senior Clinician Scientist Investigator Award. A whole food, plant-based diet has shown benefits for patients with chronic kidney disease (CKD). Since the onset of the pandemic, cardiovascular complications have been seen in patients with CKD and COVID-19. SGLT-2is are associated with reduced risk of mortality in patients with type 2 diabetes and acute kidney disease. Current practice guidelines do not address dietary management specific to diabetic kidney disease (DKD). West Virginia University Medicine will partner with Interwell Health to provide value-based kidney care. The ASN HDU Home Dialysis Scholarship Program will continue in 2024. A study found that countries in low-resource settings show substantially diminished capacity for kidney care delivery. Humana and Strive Health announced a partnership to provide value-based kidney care to more Medicare Advantage plan members.